ADVANCED HEPATOCELLULAR CARCINOMA
Clinical trials for ADVANCED HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for liver cancer patients who have run out of options
Disease control CompletedThis study tested whether the drug sorafenib could help control advanced liver cancer in patients whose disease had worsened after at least one prior treatment. Fifty participants took a daily pill and were monitored to see if the cancer stopped growing and how long they lived. T…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Bo Hyun Kim • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug duo aims to control advanced liver cancer
Disease control CompletedThis study tested a combination of two drugs, futibatinib and pembrolizumab, for people with advanced liver cancer that had spread and stopped responding to initial treatment. The goal was to see if the combination could help control the cancer's growth and extend the time before…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Two-Drug attack aims to outsmart liver Cancer's stronghold
Disease control CompletedThis study tested if combining two drugs (atezolizumab and bevacizumab) could better control advanced liver cancer, especially tumors inside the liver itself. It involved 131 patients with advanced liver cancer who received this combination as their first treatment. Researchers s…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Sponsor: CHA University • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New scan could give doctors clearer picture of liver cancer fight
Diagnosis CompletedThis study tested whether a new type of PET scan could improve how doctors monitor advanced liver cancer during immunotherapy. Researchers used a special radioactive tracer designed to stick to liver cancer cells to see if the scans provided a clearer picture of how the cancer wa…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC